研究领域
Dr. Darvesh is a behavioural neurologist and trained organic chemist with interest in medicinal chemistry. His research has been instrumental in determining the importance and expression of butyrylcholinesterase in the human brain. His research focus is the development of therapeutic and diagnostic agents for Alzheimer’s disease, with butyrylcholinesterase as the target.
近期论文
查看导师新发文章
(温馨提示:请注意重名现象,建议点开原文通过作者单位确认)
Macdonald IR, Maxwell SP, Reid GA, Cash MK, DeBay DR, Darvesh S. 2017. Quantification of butyrylcholinesterase activity as a sensitive and specific biomarker of Alzheimer's disease. Journal of Alzheimer`s Disease. 58(2):491-505. PMID: 28453492
DeBay DR, Reid GA, Pottie I, Martin E, Bowen CV, Darvesh S. 2017. Targeting butyrylcholinesterase for preclinical single photon emission computed tomography (SPECT) imaging of Alzheimer's disease. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 3(2): 166-176. DOI: http://dx.doi.org/10.1016/j.trci.2017.01.005
Darvesh S. 2016. Butyrylcholinesterase as a diagnostic and therapeutic target for Alzheimer’s disease. Current Alzheimer Research. 13(10): 1173-1177. PMID: 27040140
Macdonald IR, Reid GA, Pottie IR, Martin E, Darvesh S. 2016. Synthesis and preliminary evaluation of phenyl 4-123I-iodophenylcarbamate for visualization of cholinesterases associated with alzheimer's disease pathology. Journal of Nuclear Medicine. 57: 297-302. PMID: 26541777
Darvesh S, Hopkins DA, Geula C. 2003. Neurobiology of butyrylcholinesterase. Nature Reviews Neuroscience. 4(2): 131-138. PMID: 12563284